SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PTN - Palatin Technologies Inc.
PTN 14.61-8.7%Dec 26 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10PreviousNext  
To: scaram(o)uche who wrote (141)2/1/2007 8:19:49 AM
From: blankmind   of 142
 
- I've been holding PTN for a while - i think the adverse side affects don't mean a whole lot b/c in real life - people can use Palatin's ED drug on a periodic basis as opposed to daily - hence - nearly eliminating any side affect issues from daily usage

- on the Astra Zeneca deal - i think it shows that PTN has a "class" of drugs & a pipeline as oppposed to a 1-hit wonder & this should really help the company & its stock price down the road
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10PreviousNext